The Ministry of Health and Family Welfare, Government of India has recently prohibited the manufacture for sale, sale or distribution for human use of 328 fixed dose combinations (FDCs) with immediate effect, including FDCs in diabetes.
All of us have read the Government’s notification on FDCs and it has generated some confusion and also raised several questions as to what is allowed and what is not allowed.
Let us talk about the rationality of use of FDCs in diabetes. ...read more
The right to health is now generally recognised as a fundamental Human Right by most countries. The Sustainable Development Goal, SDG 3 mandates governments to “ensure healthy lives and promote well-being for all at all stages”.... read more
More than four decades after she suffered 3rd and 4th degree burns during a napalm attack carried out by South Vietnamese airplanes during the Vietnam War, the Vietnamese woman, aged 9 years then (1972), experienced significant improvement in her pain and burn scars after she underwent laser treatment.... read more
In a policy statement published Sept. 17, 2018 online in the journal Pediatrics, the American Academy of Pediatrics (AAP) has urged support and care of transgender and gender-diverse children and adolescents and states “Transgender and gender-diverse children face many challenges in life, but, like all children,... read more
A topical formulation of the JAK1/2 inhibitor ruxolitinib (1.5%) administered twice daily led to dose-dependent improvement of 71.6% in atopic dermatitis in a phase II randomized trial presented at the European Academy... read more
Among pediatric patients with relapsing multiple sclerosis, fingolimod was associated with a lower rate of relapse and less accumulation of lesions on MRI over a 2-year period than interferon beta-1a but was associated with a higher rate... read more
The American Thoracic Society (ATS) has published a clinical practice guideline for the role of weight management in the treatment of adult obstructive sleep apnea (OSA). The Expert Panel made a strong recommendation that patients with OSA who are overweight or obese be treated with comprehensive lifestyle intervention consisting of a reduced-calorie diet,... read more
A study presented at the European Respiratory Society International Congress in Paris, France has suggested that people with asthma are more likely to go on to become obese. Those who develop asthma as adults and those who have non-allergic asthma... read more
Dr K K Aggarwal appointed President (Elect), Confederation of Medical Associations of Asia and Oceania (CMAAO) at the 2018 CMAAO General Assembly Universal access to health and wellness will be the focal point of Dr Aggarwal’s efforts for the next one year
CMAAO is a 50-year-old body with 19 member National Medical Associations
New Delhi 17th September 2018: Padma Shri Awardee, Dr K K Aggarwal, President, HCFI, took over as the President (Elect), Confederation of Medical Associations of Asia and Oceania (CMAAO) on 14th September 2018. He was appointed to the prestigious body as part of the 2018 CMAAO General Assembly held at Penang, Malaysia. An advocator of preventive and universal healthcare, Dr Aggarwal has already pioneered leading health initiatives in India.
A renowned physician, cardiologist, spiritual writer, and motivational speaker, Dr Aggarwal was the Past National President of the Indian Medical Association (IMA). He was the 1st Vice President of CMAAO and Advisor to the Ethics Committee, World Medical Association. A doctor and social worker par excellence, Dr Aggarwal is also recipient of Dr B C Roy National Award.